Evaluation of Important Prognostic Clinical and Pathological Factors in Gastric Cancer | Anticancer Research
Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer
Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery
Lynparza Improves Overall Survival in High-Risk Gastric Cancer - CancerConnect
Cancers | Free Full-Text | Statin Use Improves Overall Survival of Patients with Gastric Cancer after Surgery and Adjuvant Chemotherapy in Taiwan: A Nationwide Matched Cohort Study
Overall survival (OS) curves in each gastric cancer (GC) pathological... | Download Scientific Diagram
Characteristics and prognosis of gastric cancer in young patients
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy | BMC Cancer | Full Text
Overall survival analyses of gastric cancer (GC) samples from TCGA... | Download Scientific Diagram
Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007) | Gastric Cancer
The survival curves for each gastric cancer pTNM stage. (A) Overall... | Download Scientific Diagram
Overall survival curves for metastatic gastric cancer patients treated... | Download Scientific Diagram
Overall survival (OS) rates of patients with metastatic gastric cancer... | Download Scientific Diagram
Efficacy Data | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Sensitivity to chemotherapy may guide treatment of patients with stomach cancer
Gastric Cancer Disparities Among Asian American Subpopulations | Anticancer Research
Kaplan–Meier curves of overall survival (Os) in gastric cancer patients... | Download Scientific Diagram
A model established using marital status and other factors from the Surveillance, Epidemiology, and End Results database for early stage gastric cancer - Lixiang Zhang, Baichuan Zhou, Panquan Luo, Aman Xu, Wenxiu
JCM | Free Full-Text | Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
Comparison of treatment strategies and survival of early-onset gastric cancer: a population-based study | Scientific Reports
Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study | BMJ Open
Prognostic factors for survival in patients with gastric adenocarcinoma - Poonyam - 2021 - Cancer Reports - Wiley Online Library
Gastric cancer - The Lancet
